Michael G. E. OʼRourke

Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/dendritic cell vaccine

Michael G. E. OʼRourke, Maree K. Johnson, Catherine Lanagan et al. · Cancer Immunology Immunotherapy · 2003 · 186 citations · Full text

Medicine, Immunology, Oncology +16

Microarray expression profiling in melanoma reveals a BRAF mutation signature

Sandra Pavey, Peter A. Johansson, Leisl Packer et al. · Oncogene · 2004 · 184 citations

Life Sciences, Molecular Biology, Oncology +16

A case report: Immune responses and clinical course of the first human use of granulocyte/macrophage-colony-stimulating-factor-transduced autologous melanoma cells for immunotherapy

K.A.O. Ellem, Michael G. E. OʼRourke, Gregory R. Johnson et al. · Cancer Immunology Immunotherapy · 1997 · 101 citations · Full text

Medicine, Immunology, Oncology +15

Merkel Cell Tumor with Spontaneous Regression

Michael G. E. OʼRourke, JOHN R. BELL · The Journal of Dermatologic Surgery and Oncology · 1986 · 77 citations

Medicine, Dermatology, Oncology +10

MANAGEMENT OF MERKEL CELL TUMOUR

Robert G. Bourne, Michael G. E. OʼRourke · Australian and New Zealand Journal of Surgery · 1988 · 56 citations

Medicine, Oncology, Surgery +15